LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220K904. A total of 2 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,801,000 | +158.8% | 15,100 | +132.3% | 0.00% | +100.0% |
| Q1 2016 | $696,000 | +5.3% | 6,500 | +6.6% | 0.00% | 0.0% |
| Q4 2015 | $661,000 | -17.9% | 6,100 | -35.1% | 0.00% | 0.0% |
| Q3 2015 | $805,000 | -22.5% | 9,400 | -8.7% | 0.00% | 0.0% |
| Q2 2015 | $1,039,000 | +79.8% | 10,300 | +37.3% | 0.00% | 0.0% |
| Q1 2015 | $578,000 | +2.5% | 7,500 | -29.2% | 0.00% | 0.0% |
| Q4 2014 | $564,000 | +64.4% | 10,600 | +45.2% | 0.00% | – |
| Q3 2014 | $343,000 | -36.7% | 7,300 | -16.1% | 0.00% | -100.0% |
| Q2 2014 | $542,000 | -24.7% | 8,700 | -18.7% | 0.00% | 0.0% |
| Q1 2014 | $720,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 5,300 | $282,000 | 0.00% |
| Citadel Advisors | 10,600 | $564,000 | 0.00% |